Svetlana Vitalievna Lomteva

Svetlana Vitalievna Lomteva

Auto-generated profile, based on publicly available information

Svetlana Vitalievna Lomteva

Southern Federal University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Baghdad Science Journal
Verified
Journal Article
Open access
PDF file
LVLomteva S V
Lomteva S V
TSTatiana Shkurat
Tatiana Shkurat
BSBugrimova E S
Bugrimova E S
ZSZolotykh O S
Zolotykh O S
AAAlexandrova A A
Alexandrova A A
KVKarantysh G V
Karantysh G V
Polycystic ovary syndrome (PCOS) is the main cause of female infertility. The role of insulin resistance in the development of polycystic ovary is actively discussed here. The study included patients with PCOS without insulin resistance (n = 48) and with insulin resistance (n = 39). The comparison groups were patients with no history of PCOS: a control group without insulin resistance (n = 46) and a group of patients with insulin resistance (n = 45). The following parameters were determined in patients: FSH, LH, TSH, T3f, T4f, PRL, E2, 17-OHd, Pr, AMH, Test total, Testf, DHEAS, DHEASs, SHBG, ACTH, cortisol, IRI, IGF-1, C-peptide, and glucose level. The HOMA-IR index and the LH / FSH ratio and the total / SHBG test were calculated. Correlation analysis was also performed between HOMA IR and indicators of the hormonal profile, IGF-1, and C-peptide.Unidirectional changes in the levels of the following hormones were found in insulin resistance, PCOS and / or insulin resistance relative to control values: estradiol, total testosterone, cortisol, prolactin, AMG, and SHBG. As a result of the correlation analysis, negative relationships were established between the HOMA IR Index and the levels of E2, cortisol and AMH in patients (except for the control group).We assume that the formation of the phenotype of polycystic ovary with a combination of insulin resistance can be formed in patients with insulin resistance as a result of a decrease in the level of estradiol, SHBG and an increase in the content of total testosterone and AMH.


26 October 2024 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
OLOlga Lyangasova
Olga Lyangasova
SLSvetlana V. Lomteva
Svetlana V. Lomteva
KSKarina Y. Sagamonova
Karina Y. Sagamonova
EBElena Butenko
Elena Butenko
TSTatiana Shkurat
Tatiana Shkurat
Background: Predicting the number of follicles obtained after controlled ovarian stimulation (COS) is challenging, especially considering individual variability. Since FSH is a fundamental hormone that controls growing follicle activity, genetic variants are predicted to affect ovarian response to stimulation. The aim of the study: The purpose of this study was to analyze whether FSHB rs10835638 and FSHR rs6166 genetic variants in combination with clinical parameters might be considered as potential precise predictors of ovarian response during COS. Materials and methods: The present study included 144 women from infertile couples who underwent assisted reproductive technologies. Women with reduced FSH and/or AMH serum levels were excluded from the study. Genotyping was carried out applying restriction fragment length polymorphism analysis. Results: Genotypes frequencies for FSHB rs10835638 and FSHR rs6166 were GG (73%), GT (24%), TT (3%) and AA (42%), AG (39%), GG (19%), respectively. FSHR rs6166 GG genotype was shown as associated with higher early follicular phase serum FSH, LH and progesterone levels, compared to AA and AG genotypes. Logistic regressive models that simultaneously use the patient’s genetic and clinical characteristics to calculate the probability of low or high ovarian response have been developed. Conclusion: The present study suggests that rs10835638 and rs6166 genetic variants affect hypothalamic-pituitary–gonadal hormones serum levels, and together may provide an improved model for predicting an ovarian response during COS.

15 October 2025 in Ecological genetics
Verified
Journal Article
Closed access
СЛСветлана Витальевна Ломтева
Светлана Витальевна Ломтева
Oxidative stress is a major factor in the development and progression of polycystic ovary syndrome. It drives metabolic disturbances, systemic inflammation, and ovarian dysfunction. Excessive production of reactive oxygen species, combined with weakened antioxidant defenses, exacerbates insulin resistance, hyperandrogenism, and impaired folliculogenesis. Genetic variations in antioxidant genes further influence this imbalance, shaping individual susceptibility to the syndrome. His review summarizes the role of key antioxidant defense genes, including SOD2, GPX1, GPX4, CAT, and PON1, and examines their associations with polycystic ovary syndrome risk and clinical outcomes. Polymorphism, such as SOD2 rs4880 and GPX4 rs713041 show relatively consistent links with polycystic ovary syndrome, whereas other variants display population-specific effects. Understanding the genetic basis of oxidative stress may advance biomarker discovery and support the development of personalized therapeutic strategies for women with this disease. The development of precision therapy protocols for this syndrome, taking into account genetic testing and lifestyle data, will help improve the reproductive and metabolic health of women with polycystic ovary syndrome.

28 June 2024 in RESEARCH RESULTS IN BIOMEDICINE
Verified
Journal Article
Open access
RARuba M. Ali
Ruba M. Ali
SUSouthern Federal University
Southern Federal University
SLSvetlana V. Lomteva
Svetlana V. Lomteva
AAAnzhela A. Aleksandrova
Anzhela A. Aleksandrova
KSKarina Yu. Sagamonova
Karina Yu. Sagamonova
RURostov State Medical University
Rostov State Medical University
Background: Hyperandrogenism is the basic indicator of polycystic ovarian syndrome (PCOS) and a ...

8 December 2025 in Preprints.ru
Verified
Preprint
Open access
СЛСветлана Ломтева
Светлана Ломтева
АСАртур Сагомонов
Артур Сагомонов
ЕХЕвгения Харченко
Евгения Харченко
Синдром поликистоза яичников (СПЯ) часто сочетается с хроническим окислительным стрессом, нарушающим инсулиновую сигнализацию и оогенез. Цель исследования: Систематизировать микроРНК, непосредственно регулирующие гены окислительного стресса при СПЯ. Методы: Анализ публикаций за последние 25 лет для сопоставление мишеней микроРНК с путями антиоксидантной защиты с использованием баз данных: HMDD, PCOSKB и miRTargetLink 2.0. Результаты: miR-145 подавляет пролиферацию гранулёзных клеток, ингибируя сигнальный путь IRS1/MAPK ERK; miR-16 воздействует на PDCD4 и подавляет апоптоз; miR-323-3p регулирует гены IGF1/PDCD4; miR-324-3p регулирует пролиферацию и апоптоз в гранулезных клетках посредством воздействия на ген WNT2B; miR-222 подавляет экспрессию SOD2; miR-27a участвует в фолликулогенезе, регулирует ген Nrf2; miR-93 подавляет активность антиоксидантного гена NFE2L2 и стимулирует апоптоз; miR-21 участвует в развитии фолликулов и стероидогенезе, усиливакет продукцию активных форм кислорода и подавляет активность SOD2 и SOD3. Заключение: Показано, что miR-145; miR-323-3p; miR-324-3p; miR-146a; miR-93 и miR-21 могут служить диагностическими/прогностическими маркерами и мишенями терапии СПЯ, что в конечном итоге может улучшить фертильность, метаболическое здоровье и качество жизни у женщин с СПЯ.